Jeff Goater is a Partner at The Column Group, which he joined in 2021. Prior to joining TCG, he was an operator helping to build and lead biotechnology companies, including serving as CEO of Surface Oncology and CFO of Voyager Therapeutics.  Previously, Mr. Goater spent nearly a decade in investment banking, most recently as a managing director at Evercore. He began his career as a research scientist in the field of AAV gene therapy and holds master’s degrees in microbiology/immunology (M.S.), pathology (M.S.) and business administration (M.B.A.) from the University of Rochester.